RBC Capital Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX)
In a report released today, Brian Abrahams from RBC Capital maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with a ...
InsuranceNewsNet11h
Proxy Statement (Form DEF 14A)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549. You are invited to attend the 2025 annual meeting of shareholders of HarborOne Bancorp, Inc., which will be held on May 13, ...